StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PLSEBullishAnalyst Target Updateanalyst
Medium materiality5/10

Needham Reiterates Buy on Pulse Biosciences

Nov 17, 2026, 12:11 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish, based on the analyst’s rating and target; confidence is limited because no new company-specific catalyst is provided.

AI summary

What happened, with direct paths to the underlying reporting

Needham reiterated its Buy rating on PLSE with a $64 target versus a posted price of $45.12, indicating meaningful analyst-estimated upside. The target remains an opinion rather than a confirmed catalyst.

  • $64 target vs. $45.12 posted price
  • Needham reiterated Buy

Key facts

  1. 01

    Target: $64

  2. 02

    Posted price: $45.12

  3. 03

    Analyst firm: Needham

  4. 04

    Analyst: Mike Matson

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.